Among IL-6 cytokine family members, IL-6 has the most well-defined effect on the TME by prompting chronic inflammatory responses, regulating tumor vasculogenesis and the outgrowth of heterogeneous cells, and preventing Th1 cell-mediated antitumor immunocytotoxicity [26]. This evidence concerns the gene IL6 and neoplasm.